In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes through) become one company, combining Recursion’s expertise in biology with Exscientia’s focus on chemistry.

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Texas A&M run-ruled Texas 14-2 in the SEC Tournament semifinal. The championship game against Oklahoma was initially rescheduled due to rain, then ultimately canceled. Texas A&M and Oklahoma were ...

Real time quote data is not available at this time. *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green ...

Easy-to-understand visualizations for Ranked-Choice Voting elections: sankey, bargraphs, and tables. Interactive and print-friendly options available. Supports most common tabulators.